Allergan (NYSE:AGN) reported on Tuesday first quarter earnings that missed analysts' forecasts and revenue that fell short of expectations.
Allergan announced earnings per share of $1.14 on revenue of $3.60B. Analysts polled by anticipated EPS of $3.95 on revenue of $3.79B. That with comparison to EPS of $3.79 on revenue of $3.6B in the same period a year before. Allergan had reported EPS of $5.22 on revenue of $4.35B in the previous quarter. Analysts are expecting EPS of $3.58 and revenue of $3.67B in the upcoming quarter.
Allergan shares are up 0.97% from the beginning of the year , still down 4.55% from its 52 week high of $202.22 set on February 12. They are outperforming the S&P 500 which is down 9.7% year to date.
Allergan follows other major Healthcare sector earnings this month
Allergan's report follows an earnings beat by J&J on April 14, who reported EPS of $2.3 on revenue of $20.69B, compared to forecasts EPS of $2.02 on revenue of $19.73B.
Pfizer had beat expectations on April 28 with first quarter EPS of $0.8 on revenue of $12.03B, compared to forecast for EPS of $0.73 on revenue of $11.81B.
Stay up-to-date on all of the upcoming earnings reports by visiting 's earnings calendar
